RS

Renu Srivastava

Active Director Director DIN 10737484
DIN 10737484 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Renu Srivastava

Data last updated:

Renu Srivastava is a Director at Nrd Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10737484
Primary Designation Director
Industry Pharma
First Appointment 09 Aug 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nrd Pharmaceuticals Private Limited U47720UT2024PTC017823
Director09 Aug 20242024Active

Board colleagues of Renu Srivastava

NameDINCompanyDesignation
Nikita Singh10737485Nrd Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nrd Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Renu Srivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Srivastava

Renu Srivastava currently holds 1 directorship: Nrd Pharmaceuticals Private Limited (Director, since 09 Aug 2024).

Renu Srivastava was first appointed on 09 Aug 2024 as Director at Nrd Pharmaceuticals Private Limited.

The current boards of Renu Srivastava's companies include Nikita Singh (Nrd Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available